Clinical trial Recruiting at 1 site Observational Ages 18 and up

Diagnosing joint diseases using biomarkers from joint fluid and tissue

Official title: "Translating Articular Biomarkers Into Diagnoses"

Run by Assistance Publique - Hôpitaux de Paris · NCT06312943 · Data updated 2026-11-12

This observational study tests whether new and traditional biomarkers from synovial fluid, blood, or joint tissue can help diagnose inflammatory and non-inflammatory joint diseases earlier and more accurately.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris, IDF)
StatusRecruiting
StartedJune 2, 2026
Main results expectedJune 2029
Study endsAugust 2029
Registry record updatedJune 24, 2026
Trial IDNCT06312943 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older with inflammatory or non-inflammatory bone and joint diseases requiring synovial fluid aspiration or joint replacement, who can communicate in French.

Probably not a fit

Patients who do not require joint fluid collection or tissue samples, or who cannot communicate in French, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will collect joint fluid or tissue samples from adults with bone and joint diseases to explore biomarkers from both conventional tests and newer methods like Raman spectroscopy. The study aims to see if these biomarkers can refine diagnoses and better classify patients who currently have unclear or unclassified rheumatic conditions. No intervention beyond sample collection is planned, and analysis will focus on diagnostic information from the specimens. Findings could improve early detection and inform treatment decisions in rheumatic diseases.

Why it matters

Potential benefit: If successful, the approach could lead to earlier and more accurate diagnoses for patients with unclear joint diseases.

How similar studies have gone: Previous work in this area has shown promise with biomarker-based approaches, but the combination with Raman and nanospectroscopy in routine diagnostic pathways is still evolving.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Inflammatory and non-inflammatory bone and joint diseases requiring synovial fluid aspiration and/or joint replacement
* Collection of non-opposition
* Affiliated to or beneficiary of social security

Exclusion Criteria:

* Inability to speak and/or read French
* Neoadjuvant therapy
* Patients under tutor or curatorship
* Protected adults,
* Patients benefiting of State Medical Aid

Where it's running

  • Service de Médecine Physique et de Réadaptation, Hôpital Cochin
    Paris, Idf, France
    Recruiting

Study contacts

  • Principal investigator: Christelle Nguyen, MD, PhD — Service de Médecine Physique et de Réadaptation, Hôpital Cochin
  • Study coordinator: Christelle Nguyen, MD, PhD
  • Email: christelle.nguyen2@aphp.fr
  • Phone: 00 33 1 58 41 29 45

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.